Business Advisory services                  Life Sciences Consulting                  Product Development                  ANDAs                  FTFs                  505 b 2 a                  Late Stage Assets                  Phase-II Trials                  Marketing Authorizationís                  Dossiers                  Site Transfers                  Scale ups                   Tail End Brands                  Technologies and Know-how                  Project Management                   Business Excellence & Six Sigma
Garphi worked with a North American biotechnology company to help them understand the potential value of a development-stage enabling technology. Garphi interviewed area-specific opinion leaders, identified relevant strengths and weaknesses of the technology and estimated the value to potential to licensing partners. This work helped define an appropriate range of deal terms based on the stage of the product and historical deals
  • Performed analysis of licensing terms of comparable technologies
  • Created sample term sheet to aid in negotiations of licensing terms
  • Supported business development activities in preparation for licensing discussions